Focal Radiotherapy for Previously Treated Prostate Cancer Patients
Phase I Feasibility Trial of Stereotactic Re-irradiation of Prostate Cancer Recurrence Within the Definitively Irradiated Prostate
Sponsor: Northern Sydney and Central Coast Area Health Service
This NA trial investigates Locally Recurrent Prostate Cancer and is currently actively recruiting participants. Northern Sydney and Central Coast Area Health Service leads this study, which shows 14 recorded versions since 2017 — indicating substantial longitudinal coverage. As an oncology study, it adds to the longitudinal record of treatment development for this indication.
Status Flow
Change History
14 versions recorded-
Feb 2026 — Present [monthly]
Recruiting NA
-
Sep 2024 — Feb 2026 [monthly]
Recruiting NA
-
Jul 2024 — Sep 2024 [monthly]
Recruiting NA
-
Dec 2023 — Jul 2024 [monthly]
Recruiting NA
-
Nov 2022 — Dec 2023 [monthly]
Recruiting NA
▶ Show 9 earlier versions
-
Feb 2022 — Nov 2022 [monthly]
Recruiting NA
-
Jan 2021 — Feb 2022 [monthly]
Recruiting NA
-
Apr 2020 — Jan 2021 [monthly]
Recruiting NA
-
Oct 2019 — Apr 2020 [monthly]
Recruiting NA
-
Apr 2019 — Oct 2019 [monthly]
Recruiting NA
-
Feb 2019 — Apr 2019 [monthly]
Recruiting NA
-
Jun 2018 — Feb 2019 [monthly]
Recruiting NA
-
Oct 2017 — Jun 2018 [monthly]
Recruiting NA
-
May 2017 — Oct 2017 [monthly]
Recruiting NA
First recorded
Apr 2017
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Northern Sydney and Central Coast Area Health Service
- Royal North Shore Hospital
For direct contact, visit the study record on ClinicalTrials.gov .